Sumitomo Mitsui Trust Group’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.3M | Sell |
8,167,745
-311,539
| -4% | -$1.58M | 0.03% | 507 |
|
|
2025
Q1 | $44.9M | Sell |
8,479,284
-501,317
| -6% | -$2.65M | 0.03% | 469 |
|
|
2024
Q4 | $60.7M | Sell |
8,980,601
-786,127
| -8% | -$5.31M | 0.04% | 399 |
|
|
2024
Q3 | $64.4M | Sell |
9,766,728
-220,302
| -2% | -$1.45M | 0.04% | 388 |
|
|
2024
Q2 | $74.9M | Sell |
9,987,030
-375,773
| -4% | -$2.82M | 0.06% | 332 |
|
|
2024
Q1 | $103M | Buy |
10,362,803
+1,159,023
| +13% | +$11.6M | 0.07% | 286 |
|
|
2023
Q4 | $90.7M | Buy |
9,203,780
+5,680,656
| +161% | +$56M | 0.07% | 314 |
|
|
2023
Q3 | $27M | Buy |
3,523,124
+2,685,724
| +321% | +$20.5M | 0.02% | 623 |
|
|
2023
Q2 | $6.26M | Buy |
837,400
+335,423
| +67% | +$2.51M | ﹤0.01% | 820 |
|
|
2023
Q1 | $3.35M | Buy |
501,977
+47,455
| +10% | +$317K | ﹤0.01% | 866 |
|
|
2022
Q4 | $3.5M | Sell |
454,522
-36,218
| -7% | -$279K | ﹤0.01% | 877 |
|
|
2022
Q3 | $5.22M | Buy |
490,740
+90,839
| +23% | +$966K | ﹤0.01% | 842 |
|
|
2022
Q2 | $3.26M | Buy |
+399,901
| New | +$3.26M | ﹤0.01% | 904 |
|
|
2022
Q1 | – | Sell |
-368,994
| Closed | -$6.32M | – | 1230 |
|
|
2021
Q4 | $6.32M | Sell |
368,994
-40,200
| -10% | -$689K | ﹤0.01% | 817 |
|
|
2021
Q3 | $9.42M | Buy |
409,194
+195,586
| +92% | +$4.5M | 0.01% | 781 |
|
|
2021
Q2 | $7.8M | Buy |
+213,608
| New | +$7.8M | ﹤0.01% | 816 |
|